🕒 Thursday 27 August 2026 Thu, 27 Aug 2026

Syntara Limited’s FY2026 results show a 7.9% revenue decline and a 13.6% increase in net loss amid significant clinical progress, including FDA backing for its lead drug amsulostat and a successful $8.8 million capital raise.

RocketBoots reported a 9.7% revenue rise to A$724,815 but deepened its net loss to A$6.6 million, driven by heavy investment ahead of a major contract rollout and international growth.

OM Holdings reversed a loss to report a US$26.3 million profit in 1H 2026, driven by a major asset disposal and improved product margins despite lower sales volumes.

MA Credit Income Trust (ASX:MA1) posted a robust 8.56% net return for FY2026, surpassing its target, alongside a fully subscribed $190.5 million capital raise and strategic buy-back initiatives.

Pengana Private Equity Trust (ASX: PE1) posted a 23.2% net return for FY2026, powered by a dramatic revaluation of SpaceX and strong gains across a diversified private equity portfolio.

Jumbo Interactive has delivered a record FY26 underlying EBITDA of $85.2 million, driven by strong Australian lottery retailing and international B2C growth. The company maintains a robust balance sheet and outlines ambitious FY27 targets amid ongoing integration of UK and US acquisitions.

AI Private Opportunities Trust (ASX: AIX) has completed its first reporting period, raising $267 million and beginning deployment into high-profile private AI companies including ByteDance and Databricks.

Winton Land’s governance is under strain after independent directors Steven Joyce and Guy Fergusson resigned citing conflicts with the majority shareholder. The board must urgently appoint new independent directors to maintain NZX compliance and avoid potential trading suspension.

Saferoads Holdings (ASX:SRH) doubled its revenue to $12.47 million in FY2026, swinging to a $711,000 profit from continuing operations after divesting its Road Safety Rental business. The company declared a fully franked final dividend of 0.5 cents per share.

Biotron Limited posted a $1.52 million net loss for FY2026, driven by integration and R&D costs following its Sedarex acquisition, while progressing regulatory and clinical development for its SedRxTM anaesthetic and antiviral pipeline.

UOA Development Bhd reported a 70% rise in quarterly revenue to RM221.2 million and a modest profit increase to RM95.6 million, driven by ongoing projects and robust new property sales.

Webjet Group navigated a challenging FY26 with flat OTA revenue and strong EBITDA margins, while its Cars & Motorhomes segment began turning around. The company withheld FY27 earnings guidance, citing ongoing macro uncertainty but noted improved recent trading.

SenSen Networks reported a 16.7% rise in annualised recurring revenue to $11.7 million and a 23.6% EBITDA increase to $2.0 million in FY26, while expanding its SenDISA platform into environmental enforcement with EPA Victoria.

Clarity Pharmaceuticals reported a 67% increase in net loss to $107.2 million for FY26, driven by higher R&D spending, while advancing multiple Phase III trials and expanding manufacturing capacity ahead of commercialisation.

Clinuvel Pharmaceuticals marked its tenth consecutive profit with stable revenues and rising cash reserves, while accelerating U.S. expansion including a Nasdaq uplisting and potential ASX delisting.

Aeris Resources delivered a standout FY26 with revenues up 22% and profit after tax surging 295%, buoyed by operational gains and a strategic acquisition of Peel Mining.

Careteq Limited (ASX: CTQ) reported a $398K net loss for FY26 amid a strategic reset that included selling its Embedded Health Solutions business and repaying all debt. The company now pivots fully to growing its HMR Referrals platform with $3.19 million cash on hand.

BlackWall Limited posted a $2.4 million statutory loss for FY2026, driven by operating setbacks and unrealised asset write-downs. The company suspends dividends after exhausting franking credits and proposes a share buy-back offering WOT securities in lieu of cash.

Hubify Limited posted an 89% jump in FY26 EBITDA to $0.66 million despite a 5% revenue dip, driven by a strategic shift to higher-margin managed technology and advisory services and a robust cash position of $3.79 million.

NTAW Holdings reported a 15.7% revenue drop to $445.3 million in FY2026 but improved net losses and operating EBITDA amid a strategic reset. The company divested its South African stake and plans asset sales as it targets modest growth in FY2027.

NewPeak Metals has finalised its second tranche placement, issuing over 231 million shares and raising $2.86 million before costs, including repayment of director entitlements.

Global Health Limited trimmed its FY26 net loss by 12.5% to A$758,220, driven by a 5.5% lift in recurring SaaS revenue and a 20% cut in employee costs aided by AI integration, though going concern risks remain.

Butn Limited reported a 5% revenue increase to $15.3 million in FY26, driven by strong platform growth and strategic simplification, while net loss widened 44% to $3.8 million amid higher bad debts and one-off costs.

ImpediMed reported a 15% revenue increase to $14.6 million in FY26, broadened reimbursement coverage for its SOZO platform to 95% of the US population, and launched new applications in heart health and weight management.